Charles Bancroft

Charles Bancroft appears in our data through filings on GSK plc shares, published by RNS (LSE). The record holds 31 filings, for trades running from 20 June 2023 to 9 October 2026.

No open-market sale appears; the market trades are 16 purchases worth €1.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 15 share grants. In 2026 alone, the filings show 4 purchases and no sales.

In size, the median ticket on the buying side is €88k. On 14 out of 14 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 13 October 2026 with a share grant (€17k) in GSK plc. The most recent open-market purchase was published on 22 September 2026, 25 days ago. Filings reach the RNS (LSE) feed a median of 3 days after the trade. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.